REFRACTORY ANEMIA

Clinical trials for REFRACTORY ANEMIA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY ANEMIA trials appear

Sign up with your email to follow new studies for REFRACTORY ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

New drug duo aims to control aggressive blood cancers

Disease control Ongoing

This study is testing the safety and effectiveness of combining two drugs, vorinostat and azacitidine, for patients with myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML). The goal is to find the best dose and see if the combination can better control the disease by…

Matched conditions: REFRACTORY ANEMIA

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

REFRACTORY ANEMIA

Get alerted when new REFRACTORY ANEMIA trials appear

New drug duo aims to control aggressive blood cancers